Literature DB >> 33772158

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.

Clive Hoggart1,2, Chisato Shimizu3, Jane C Burns3,4, Michael Levin5, Rachel Galassini5, Victoria J Wright5, Hannah Shailes5, Evan Bellos5, Jethro A Herberg5, Andrew J Pollard6, Daniel O'Connor6, Shing Wan Choi7, Eleanor G Seaby5, Stephanie Menikou5, Martin Hibberd8, Neneh Sallah8, David Burgner9, Paul Brogan10, Harsita Patel5, Jihoon Kim11, Adriana H Tremoulet3,4, Eeva Salo12, Diana van Stijn13,14, Taco Kuijpers13,14.   

Abstract

Kawasaki disease (KD) is a paediatric vasculitis associated with coronary artery aneurysms (CAA). Genetic variants influencing susceptibility to KD have been previously identified, but no risk alleles have been validated that influence CAA formation. We conducted a genome-wide association study (GWAS) for CAA in KD patients of European descent with 200 cases and 276 controls. A second GWAS for susceptibility pooled KD cases with healthy paediatric controls from vaccine trials in the UK (n = 1609). Logistic regression mixed models were used for both GWASs. The susceptibility GWAS was meta-analysed with 400 KD cases and 6101 controls from a previous European GWAS, these results were further meta-analysed with Japanese GWASs at two putative loci. The CAA GWAS identified an intergenic region of chromosome 20q13 with multiple SNVs showing genome-wide significance. The risk allele of the most associated SNV (rs6017006) was present in 13% of cases and 4% of controls; in East Asian 1000 Genomes data, the allele was absent or rare. Susceptibility GWAS with meta-analysis with previously published European data identified two previously associated loci (ITPKC and FCGR2A). Further meta-analysis with Japanese GWAS summary data from the CASP3 and FAM167A genomic regions validated these loci in Europeans showing consistent effects of the top SNVs in both populations. We identified a novel locus for CAA in KD patients of European descent. The results suggest that different genes determine susceptibility to KD and development of CAA and future work should focus on the function of the intergenic region on chromosome 20q13.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33772158      PMCID: PMC7994355          DOI: 10.1038/s41431-021-00838-5

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  56 in total

1.  N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.

Authors:  Philippe M Adjagba; Laurent Desjardins; Anne Fournier; Linda Spigelblatt; Martine Montigny; Nagib Dahdah
Journal:  Cardiol Young       Date:  2014-12-29       Impact factor: 1.093

2.  Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.

Authors:  Robert M R Tulloh; Richard Mayon-White; Anthony Harnden; Athimalaipet V Ramanan; E Jane Tizard; Delane Shingadia; Colin A Michie; Richard M Lynn; Michael Levin; Orla D Franklin; Pippa Craggs; Sue Davidson; Rebecca Stirzaker; Mike Danson; Paul A Brogan
Journal:  Arch Dis Child       Date:  2018-08-13       Impact factor: 3.791

3.  Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.

Authors:  Shannon M Skochko; Sonia Jain; Xiaoying Sun; Nipha Sivilay; John T Kanegaye; Joan Pancheri; Chisato Shimizu; Robert Sheets; Adriana H Tremoulet; Jane C Burns
Journal:  J Pediatr       Date:  2018-09-26       Impact factor: 4.406

4.  Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.

Authors:  Lynn A Sleeper; L Luann Minich; Brian M McCrindle; Jennifer S Li; Wilbert Mason; Steven D Colan; Andrew M Atz; Beth F Printz; Annette Baker; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2010-12-18       Impact factor: 4.406

Review 5.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

6.  Cardiovascular biomarkers in acute Kawasaki disease.

Authors:  Yuichiro Z Sato; Delaram P Molkara; Lori B Daniels; Adriana H Tremoulet; Chisato Shimizu; John T Kanegaye; Brookie M Best; James V Snider; Jeffrey R Frazer; Alan Maisel; Jane C Burns
Journal:  Int J Cardiol       Date:  2011-07-20       Impact factor: 4.164

7.  Predicting IVIG resistance in UK Kawasaki disease.

Authors:  Sarah Davies; Natalina Sutton; Sarah Blackstock; Stuart Gormley; Clive J Hoggart; Michael Levin; Jethro A Herberg
Journal:  Arch Dis Child       Date:  2015-02-10       Impact factor: 3.791

8.  Resistance to intravenous immunoglobulin in children with Kawasaki disease.

Authors:  Adriana H Tremoulet; Brookie M Best; Sungchan Song; Susan Wang; Elena Corinaldesi; Julia R Eichenfield; Danielle D Martin; Jane W Newburger; Jane C Burns
Journal:  J Pediatr       Date:  2008-03-04       Impact factor: 4.406

Review 9.  The genetics of Kawasaki disease.

Authors:  Yoshihiro Onouchi
Journal:  Int J Rheum Dis       Date:  2017-11-19       Impact factor: 2.454

10.  Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.

Authors:  Shohei Ogata; Adriana H Tremoulet; Yuichiro Sato; Kayla Ueda; Chisato Shimizu; Xiaoying Sun; Sonia Jain; Laura Silverstein; Annette L Baker; Noboru Tanaka; Yoshihito Ogihara; Satoshi Ikehara; Shinichi Takatsuki; Naoko Sakamoto; Tohru Kobayashi; Shigeto Fuse; Tomoyo Matsubara; Masahiro Ishii; Tsutomu Saji; Jane W Newburger; Jane C Burns
Journal:  Int J Cardiol       Date:  2013-07-11       Impact factor: 4.164

View more
  4 in total

1.  Genomics elucidates both common and rare disease aetiology.

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2021-12       Impact factor: 4.246

2.  Identification of rare coding variants associated with Kawasaki disease by whole exome sequencing.

Authors:  Jae-Jung Kim; Young Mi Hong; Sin Weon Yun; Kyung-Yil Lee; Kyung Lim Yoon; Myung-Ki Han; Gi Beom Kim; Hong-Ryang Kil; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Hyun Ok Jun; Byung-Ok Choi; Yeon-Mok Oh; Jeong Jin Yu; Gi Young Jang; Jong-Keuk Lee
Journal:  Genomics Inform       Date:  2021-12-31

Review 3.  Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.

Authors:  Piotr Buda; Joanna Friedman-Gruszczyńska; Janusz Książyk
Journal:  Front Med (Lausanne)       Date:  2021-11-30

4.  Human Transcriptome Array Analysis Identifies CDR2 as a Novel Suppressed Gene for Kawasaki Disease.

Authors:  Ying-Hsien Huang; Kuang-Den Chen; Kuang-Che Kuo; Mindy Ming-Huey Guo; Ling-Sai Chang; Ya-Ling Yang; Ho-Chang Kuo
Journal:  Diagnostics (Basel)       Date:  2022-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.